UBS Downgrades XPeng (XPEV) to Neutral

UBS analyst Paul Gong downgraded XPeng (NYSE: XPEV) from Buy to Neutral with a price target of $23.00 (from $12.00).

For an analyst ratings summary and ratings history on XPeng click here. For more ratings news on XPeng click here.

Shares of XPeng closed at $23.39 yesterday.

You May Also Be Interested In

• TD Cowen Downgrades Foghorn Therapeutics (FHTX) to Hold
• Dynatrace Inc. (DT) PT Raised to $74 at UBS as AI Governance Concerns a Potential Catalyst
• Micron Technology (MU) PT Raised to $2,100 at DA Davidson as Memory Markets Expected to Further Tighten